Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 158

1.

Differential expression and clinical relevance of MUC1 in renal cell carcinoma metastasis.

Rausch S, Beermann J, Scharpf M, Hennenlotter J, Fend F, Stenzl A, Schollenberger D, Bedke J, Kruck S.

World J Urol. 2016 Mar 19. [Epub ahead of print]

PMID:
26995391
2.

Transcripts of circulating tumor cells detected by a breast cancer-specific platform correlate with clinical stage in bladder cancer patients.

Todenhöfer T, Hennenlotter J, Dorner N, Kühs U, Aufderklamm S, Rausch S, Bier S, Mischinger J, Schellbach D, Hauch S, Feniuk N, Bedke J, Gakis G, Stenzl A, Schwentner C.

J Cancer Res Clin Oncol. 2016 May;142(5):1013-20. doi: 10.1007/s00432-016-2129-0. Epub 2016 Feb 24.

PMID:
26910601
3.

Assessment of a new point-of-care system for detection of prostate specific antigen.

Rausch S, Hennenlotter J, Wiesenreiter J, Hohneder A, Heinkele J, Schwentner C, Stenzl A, Todenhöfer T.

BMC Urol. 2016 Jan 19;16(1):4. doi: 10.1186/s12894-016-0119-9.

4.

Return to Work and Normal Daily Life Activity after Open and Robot-Assisted Radical Prostatectomy - A Single Surgeon Analysis.

Bier S, Hennenlotter J, Rausch S, Aufderklamm S, Martzog JC, Stenzl A, Schwentner C, Todenhöfer T.

Urol Int. 2016;96(3):280-6. doi: 10.1159/000437335. Epub 2016 Jan 12.

PMID:
26752058
5.

Prostate tumor overexpressed 1 expression in invasive urothelial carcinoma.

Rausch S, Hennenlotter J, Scharpf M, Teepe K, Kühs U, Aufderklamm S, Bier S, Mischinger J, Gakis G, Stenzl A, Schwentner C, Todenhöfer T.

J Cancer Res Clin Oncol. 2016 May;142(5):937-47. doi: 10.1007/s00432-015-2107-y. Epub 2016 Jan 8.

PMID:
26746655
6.

Expression of Genes Related to Germ Cell Lineage and Pluripotency in Single Cells and Colonies of Human Adult Germ Stem Cells.

Conrad S, Azizi H, Hatami M, Kubista M, Bonin M, Hennenlotter J, Sievert KD, Skutella T.

Stem Cells Int. 2016;2016:8582526. doi: 10.1155/2016/8582526. Epub 2015 Nov 8.

7.

MCT4 surpasses the prognostic relevance of the ancillary protein CD147 in clear cell renal cell carcinoma.

Fisel P, Stühler V, Bedke J, Winter S, Rausch S, Hennenlotter J, Nies AT, Stenzl A, Scharpf M, Fend F, Kruck S, Schwab M, Schaeffeler E.

Oncotarget. 2015 Oct 13;6(31):30615-27. doi: 10.18632/oncotarget.5593.

8.

UCP-3 uncoupling protein confers hypoxia resistance to renal epithelial cells and is upregulated in renal cell carcinoma.

Braun N, Klumpp D, Hennenlotter J, Bedke J, Duranton C, Bleif M, Huber SM.

Sci Rep. 2015 Aug 25;5:13450. doi: 10.1038/srep13450.

9.

Residual γH2AX foci after ex vivo irradiation of patient samples with known tumour-type specific differences in radio-responsiveness.

Menegakis A, De Colle C, Yaromina A, Hennenlotter J, Stenzl A, Scharpf M, Fend F, Noell S, Tatagiba M, Brucker S, Wallwiener D, Boeke S, Ricardi U, Baumann M, Zips D.

Radiother Oncol. 2015 Sep;116(3):480-5. doi: 10.1016/j.radonc.2015.08.006. Epub 2015 Aug 18.

PMID:
26297183
10.

Prostate cancer gene 3 (PCA3) is of additional predictive value in patients with PI-RADS grade III (intermediate) lesions in the MR-guided re-biopsy setting for prostate cancer.

Kaufmann S, Bedke J, Gatidis S, Hennenlotter J, Kramer U, Notohamiprodjo M, Nikolaou K, Stenzl A, Kruck S.

World J Urol. 2016 Apr;34(4):509-15. doi: 10.1007/s00345-015-1655-8. Epub 2015 Aug 13.

PMID:
26267808
11.

Muscle-invasive bladder cancer is characterized by overexpression of thymidine kinase 1.

Rausch S, Hennenlotter J, Teepe K, Kuehs U, Aufderklamm S, Bier S, Mischinger J, Gakis G, Stenzl A, Schwentner C, Todenhöfer T.

Urol Oncol. 2015 Oct;33(10):426.e21-9. doi: 10.1016/j.urolonc.2015.06.007. Epub 2015 Jul 29.

PMID:
26231311
12.

Combined unsupervised-supervised classification of multiparametric PET/MRI data: application to prostate cancer.

Gatidis S, Scharpf M, Martirosian P, Bezrukov I, Küstner T, Hennenlotter J, Kruck S, Kaufmann S, Schraml C, la Fougère C, Schwenzer NF, Schmidt H.

NMR Biomed. 2015 Jul;28(7):914-22. doi: 10.1002/nbm.3329. Epub 2015 May 26.

PMID:
26014883
13.

Real-time tissue differentiation based on optical emission spectroscopy for guided electrosurgical tumor resection.

Spether D, Scharpf M, Hennenlotter J, Schwentner C, Neugebauer A, Nüßle D, Fischer K, Zappe H, Stenzl A, Fend F, Seifert A, Enderle M.

Biomed Opt Express. 2015 Mar 24;6(4):1419-28. doi: 10.1364/BOE.6.001419. eCollection 2015 Apr 1.

14.

Prognostic relevance of positive urine markers in patients with negative cystoscopy during surveillance of bladder cancer.

Todenhöfer T, Hennenlotter J, Guttenberg P, Mohrhardt S, Kuehs U, Esser M, Aufderklamm S, Bier S, Harland N, Rausch S, Gakis G, Stenzl A, Schwentner C.

BMC Cancer. 2015 Mar 19;15:155. doi: 10.1186/s12885-015-1089-0.

15.

γH2AX assay in ex vivo irradiated tumour specimens: A novel method to determine tumour radiation sensitivity in patient-derived material.

Menegakis A, von Neubeck C, Yaromina A, Thames H, Hering S, Hennenlotter J, Scharpf M, Noell S, Krause M, Zips D, Baumann M.

Radiother Oncol. 2015 Sep;116(3):473-9. doi: 10.1016/j.radonc.2015.03.026. Epub 2015 Apr 9.

PMID:
25866027
16.

PCA3 and PSA gene activity correlates with the true tumor cell burden in prostate cancer lymph node metastases.

Tsaur I, Hennenlotter J, Oppermann E, Munz M, Kuehs U, Stenzl A, Schilling D.

Cancer Biomark. 2015;15(3):311-6. doi: 10.3233/CBM-150461.

PMID:
25769446
17.

Stepwise application of urine markers to detect tumor recurrence in patients undergoing surveillance for non-muscle-invasive bladder cancer.

Todenhöfer T, Hennenlotter J, Esser M, Mohrhardt S, Aufderklamm S, Böttge J, Rausch S, Mischinger J, Bier S, Gakis G, Kuehs U, Stenzl A, Schwentner C.

Dis Markers. 2014;2014:973406. doi: 10.1155/2014/973406. Epub 2014 Dec 22.

18.

Significance of apoptotic and non-apoptotic disseminated tumor cells in the bone marrow of patients with clinically localized prostate cancer.

Todenhöfer T, Hennenlotter J, Faber F, Wallwiener D, Schilling D, Kühs U, Aufderklamm S, Bier S, Mischinger J, Gakis G, Fehm T, Stenzl A, Schwentner C.

Prostate. 2015 May;75(6):637-45. doi: 10.1002/pros.22947. Epub 2015 Jan 13.

PMID:
25586166
19.

Expression patterns and prognostic role of transketolase-like 1 in muscle-invasive bladder cancer.

Semilia M, Hennenlotter J, Pavone C, Bischoff T, Kühs U, Gakis G, Bedke J, Stenzl A, Schwentner C, Todenhöfer T.

World J Urol. 2015 Oct;33(10):1403-9. doi: 10.1007/s00345-014-1473-4. Epub 2015 Jan 9.

PMID:
25572961
20.

[Laparoscopic partial nephrectomy for renal tumors. Time for a new standard?].

Bier S, Todenhöfer T, Aufderklamm S, Hennenlotter J, Mischinger J, Sim A, Böttge J, Rausch S, Halalsheh O, Stenzl A, Gakis G, Schwentner C.

Urologe A. 2015 Jun;54(6):826-31. doi: 10.1007/s00120-014-3656-4. German.

PMID:
25297492
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk